BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21947595)

  • 1. Triple-negative breast cancer is not a contraindication for breast conservation.
    Adkins FC; Gonzalez-Angulo AM; Lei X; Hernandez-Aya LF; Mittendorf EA; Litton JK; Wagner J; Hunt KK; Woodward WA; Meric-Bernstam F
    Ann Surg Oncol; 2011 Oct; 18(11):3164-73. PubMed ID: 21947595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy.
    Abdulkarim BS; Cuartero J; Hanson J; Deschênes J; Lesniak D; Sabri S
    J Clin Oncol; 2011 Jul; 29(21):2852-8. PubMed ID: 21670451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 21-gene recurrence score and locoregional recurrence in breast cancer patients.
    Jegadeesh NK; Kim S; Prabhu RS; Oprea GM; Yu DS; Godette KG; Zelnak AB; Mister D; Switchenko JM; Torres MA
    Ann Surg Oncol; 2015 Apr; 22(4):1088-94. PubMed ID: 25472643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast-conserving surgery is not associated with increased local recurrence in patients with early-stage node-negative triple-negative breast cancer treated with neoadjuvant chemotherapy.
    Krug D; Vladimirova V; Untch M; Kühn T; Schneeweiss A; Denkert C; Ataseven B; Solbach C; Gerber B; Tesch H; Golatta M; Seiler S; Heil J; Nekljudova V; Holtschmidt J; Loibl S
    Breast; 2024 Apr; 74():103701. PubMed ID: 38422624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining Clinical and Pathologic Staging Variables Has Prognostic Value in Predicting Local-regional Recurrence Following Neoadjuvant Chemotherapy for Breast Cancer.
    Vila J; Teshome M; Tucker SL; Woodward WA; Chavez-MacGregor M; Hunt KK; Mittendorf EA
    Ann Surg; 2017 Mar; 265(3):574-580. PubMed ID: 27735826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined breast conservation therapy versus mastectomy for BRCA mutation carriers - A systematic review and meta-analysis.
    Davey MG; Davey CM; Ryan ÉJ; Lowery AJ; Kerin MJ
    Breast; 2021 Apr; 56():26-34. PubMed ID: 33582622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial and Ethnic Disparities in Locoregional Recurrence Among Patients With Hormone Receptor-Positive, Node-Negative Breast Cancer: A Post Hoc Analysis of the TAILORx Randomized Clinical Trial.
    Kantor O; King TA; Freedman RA; Mayer EL; Chavez-MacGregor M; Korde LA; Sparano JA; Mittendorf EA
    JAMA Surg; 2023 Jun; 158(6):583-591. PubMed ID: 37043210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast-conserving surgery is an appropriate procedure for centrally located breast cancer: a population-based retrospective cohort study.
    Yuan YW; Liu PC; Li FF; Yang YH; Yang W; Fan L; Mou DW; Yang HW; Chen MS
    BMC Surg; 2023 Oct; 23(1):298. PubMed ID: 37789365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of loco-regional treatment modality on the outcomes in breast cancer patients younger than forty years of age.
    Boutrus RR; Abdelazim YA; Mohammed T; Bayomy M; Ibraheem MH; Hussein A; Sebaie ME
    BMC Cancer; 2024 May; 24(1):599. PubMed ID: 38760780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Locoregional recurrence in triple negative breast cancer: past, present, and future.
    Tran J; Thaper A; Lopetegui-Lia N; Ali A
    Expert Rev Anticancer Ther; 2023; 23(10):1085-1093. PubMed ID: 37750222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local/Regional Recurrence Rates After Breast-Conserving Therapy in Patients Enrolled in Legacy Trials of the Alliance for Clinical Trials in Oncology (AFT-01).
    Schumacher JR; Wiener AA; Greenberg CC; Hanlon B; Edge SB; Ruddy KJ; Partridge AH; Le-Rademacher JG; Yu M; Vanness DJ; Yang DY; Havlena J; Strand C; Neuman HB
    Ann Surg; 2023 May; 277(5):841-845. PubMed ID: 36521077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Locoregional Breast Cancer Recurrence in the European Organisation for Research and Treatment of Cancer 10041/BIG 03-04 MINDACT Trial: Analysis of Risk Factors Including the 70-Gene Signature.
    Alaeikhanehshir S; Ajayi T; Duijnhoven FH; Poncet C; Olaniran RO; Lips EH; van 't Veer LJ; Delaloge S; Rubio IT; Thompson AM; Cardoso F; Piccart M; Rutgers EJT
    J Clin Oncol; 2024 Apr; 42(10):1124-1134. PubMed ID: 38241603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial Disparities in Locoregional Recurrence in Postmenopausal Patients with Stage I-III, Hormone Receptor-Positive Breast Cancer Enrolled in the NSABP B-42 Clinical Trial.
    Glass CC; Pride RM; Freedman RA; Mayer EL; Ogayo ER; Chavez-MacGregor M; King TA; Mittendorf EA; Kantor O
    Ann Surg Oncol; 2023 Dec; 30(13):8320-8326. PubMed ID: 37670122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-overexpression of GEP100 and AMAP1 proteins correlates with rapid local recurrence after breast conservative therapy.
    Kinoshita R; Nam JM; Ito YM; Hatanaka KC; Hashimoto A; Handa H; Otsuka Y; Hashimoto S; Onodera Y; Hosoda M; Onodera S; Shimizu S; Tanaka S; Shirato H; Tanino M; Sabe H
    PLoS One; 2013; 8(10):e76791. PubMed ID: 24116160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term locoregional recurrence in patients treated for breast cancer.
    Costeira B; da Silva FB; Fonseca F; Oom R; Costa C; Moniz JV; Abecasis N; Santos CR
    Breast Cancer Res Treat; 2023 Dec; 202(3):551-561. PubMed ID: 37707638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast conservation therapy decreased heart-specific mortality in breast cancer patients compared with mastectomy.
    Li Z; Zhao R
    BMC Surg; 2023 Aug; 23(1):233. PubMed ID: 37568124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of tumor phenotype in the surgical treatment of early-stage breast cancer.
    Rooney MM; Thomas SM; Taskindoust M; Greenup RA; Rosenberger LH; Hwang ES; Plichta JK
    Am J Surg; 2023 Jan; 225(1):84-92. PubMed ID: 36180300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Survival Outcomes between Early Breast Cancer Patients who Underwent Mastectomy and Patients Treated by Breast Conserving Therapy: A Meta Analysis.
    Manirakiza A; Irakoze L; Manirakiza S
    East Afr Health Res J; 2022; 6(1):1-10. PubMed ID: 37928868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of radiotherapy on patients with pathological stage IIB breast cancer after breast-conserving surgery or mastectomy: A cohort study.
    Pan YY; Lai TY; Shiau CY; Tseng LM; Lai IC; Liu YM; Huang PI
    J Chin Med Assoc; 2024 Feb; 87(2):202-211. PubMed ID: 38095582
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.